Russia test fires submarine-launched hypersonic Tsirkon missile for first time
- Wall St ends up with Goldman; Dow posts biggest weekly rise since June
- Goldman Sachs (GS) Smashes Analyst 3Q Views on Robust M&A and Underwriting Activity
- Tesla (TSLA) Stock: Jefferies Raises Price Target on Higher Capacity Ramp and Sustained Demand, Berlin Giga Will Set New Design and Assembly Standards Says Analyst
- Food, fuels lift U.S. import prices in September
- SEC to Allow First Ever Bitcoin (BTC) ETF - Report
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
MOSCOW (Reuters) -Russia said on Monday it had successfully test launched a Tsirkon (Zircon) hypersonic cruise missile from a submarine for the first time, a weapon President Vladimir Putin has lauded as part of a new generation of unrivalled arms systems.
The defence ministry, which tested firing the Tsirkon missile from a warship in July, said that the Severodvinsk submarine had fired the missile while deployed in the Barents Sea and had hit its chosen target.
Low-quality video footage released by the ministry showed the missile shooting upwards from a submarine, its glare lighting up the night sky and illuminating the water's surface.
"The test firing of the Tsirkon missile from a nuclear submarine was deemed successful," the ministry said.
Some Western experts have questioned how advanced Russia's new generation of weapons is, while recognising that the combination of speed, manoeuvrability and altitude of hypersonic missiles makes them difficult to track and intercept.
In July, parts of footage showing Russia's advanced new S-500 surface-to-air missile system appeared to have been deliberately blurred to make it harder to examine in detail.
Putin announced an array of new hypersonic weapons in 2018 in one of his most bellicose speeches in years, saying they could hit almost any point in the world and evade a U.S.-built missile shield.
(Reporting by Anton Kolodyazhnyy; Writing by Alexander MarrowEditing by Andrew Osborn)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump-backed challengers to Republican lawmakers lag in fundraising
- Biden aide Psaki may have violated ethics law -watchdog
- Bill Clinton to remain in hospital overnight, his health is improving -spokesman
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!